Amedisys commending Home Health Payment Innovation Act

BATON ROUGE, LA: Amedisys, Inc. (NASDAQ:AMED), America’s leading independent home health, hospice and personal care company, commends bipartisan legislation to preserve and expand home health to those who need it the most.

“Monday, our congressional champions introduced S. 433 – The Home Health Payment Innovation Act, once again showing support for home health and the value it provides to Medicare beneficiaries,” stated Amedisys President and CEO Paul Kusserow. “We look forward to seeing this policy advance so that aging Americans can continue to live independently at home.”

The bipartisan bill, introduced in Congress on Monday night, would not only preserve but also expand access for millions of Medicare beneficiaries to vitally needed health care services that are delivered to the home. This legislation, when enacted, would ensure that rate cuts due to take effect under the Patient Driven Groupings Model (PDGM) in 2020 are based on observed evidence, prohibiting CMS from making behavioral assumptions regarding home health responses to the new payment model.

Amedisys appreciates the leadership of Senator Susan Collins (R-ME), Senator Debbie Stabenow (D-MI), Senator John Kennedy (R-LA), Senator Bill Cassidy (R-LA), Senator Rand Paul (R-KY), Doug Jones (D-AL) and Jeanne Shaheen (D-NH) on this important policy. We have been working with these members and their staffs for over a year on this policy and look forward to continuing our work with these leaders, and all the members of Congress, to advance this important policy. We continue our work with House members and staff and look forward to an introduction of a companion bill very soon in the House of Representatives.